Neutralizing and non-neutralizing antibody responses in HIV-1 subtype C chronically infected patients with divergent rates of disease progression nork Archary, D, Rong, R, Gordon, M, Boliar, S, Gray, E, Dugast, A, Hermanus, T, Goulder, P, Coovadia, H, Morris, L, Alter, G, Derdeyn, C, Ndung'u, T

Characterization of anti-HIV-1 neutralizing and binding antibodies in chronic HIV-1 subtype C infection. nork Archary, D, Rong, R, Gordon, M, Boliar, S, Madiga, M, Gray, E, Dugast, A, Hermanus, T, Goulder, P, Coovadia, H, Werner, L, Morris, L, Alter, G, Derdeyn, C, Ndung'u, T

Characterization of anti-HIV-1 neutralizing and binding antibodies in chronic HIV-1 subtype C infection nork Archary, D, Rong, R, Gordon, M, Boliar, S, Madiga, M, Gray, E, Dugast, A, Hermanus, T, Goulder, P, Coovadia, H, Werner, L, Morris, L, Alter, G, Derdeyn, C, Ndung'u, T

Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity nork Ackerman, M, Crispin, M, Yu, X, Baruah, K, Boesch, A, Harvey, D, Dugast, A, Heizen, E, Ercan, A, Choi, I, Streeck, H, Nigrovic, P, Bailey-Kellogg, C, Scanlan, C, Alter, G